Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
NCT Number: NCT00181116
This study is designed to test if the language problems commonly seen in children with benign rolandic epilepsy would improve by switching anticonvulsants to levetiracetam.
Looking for future studies?
Notify Me6 year–12 year
All sexes
Interventional
Phase 4
Baltimore, Maryland, 21287, United States
This is a 6 month study in which children on another anticonvulsant would have EEG, language testing, and a clinic visit at baseline. They would then be rapidly transitioned off of their current anticonvulsant and onto levetiracetam (Keppra). Repeat EEG and language testing would be done after 6 months to evaluate for improvement.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeJohns Hopkins University
Other
Efficacy of Levetiracetam for Language Dysfunction Associated With Benign Epilepsy With Centrotemporal Spikes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05076838
Brain Diseases, Central Nervous System Diseases
Gulf Breeze, Florida, United States
View Trial DetailsNCT06352372
Autism Spectrum Disorder, Autistic Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT07827729
Brain Diseases, Central Nervous System Diseases
Malatya, Turkey (Türkiye)
View Trial DetailsNCT05152992
Anxiety, Anxiety Disorders
San Francisco, California, United States
View Trial Details